Seikagaku Corporation (TYO:4548)

Japan flag Japan · Delayed Price · Currency is JPY
679.00
-4.00 (-0.59%)
Feb 13, 2026, 3:30 PM JST
Market Cap37.08B -11.9%
Revenue (ttm)35.86B -8.7%
Net Income-755.00M
EPS-13.83
Shares Out54.60M
PE Ration/a
Forward PEn/a
Dividend30.00 (4.39%)
Ex-Dividend DateMar 30, 2026
Volume174,700
Average Volume205,810
Open682.00
Previous Close683.00
Day's Range677.00 - 686.00
52-Week Range603.00 - 800.00
Beta0.16
RSI41.68
Earnings DateFeb 6, 2026

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business. The company offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, JOYCLU Gel-One, Hylink, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand nam... [Read more]

Sector Healthcare
Founded 1947
Employees 1,075
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4548
Full Company Profile

Financial Performance

In fiscal year 2025, Seikagaku's revenue was 39.37 billion, an increase of 8.73% compared to the previous year's 36.21 billion. Earnings were 1.21 billion, a decrease of -44.46%.

Financial Statements